Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063153) titled 'Factors influencing professional identity of nurses in high-income countries... Read More
Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063151) titled 'Effect of compression values in transtibial prosthetic sockets on socket int... Read More
Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063149) titled 'Population-Based Ophthalmic Screening in Taku-shima Island, Hirado, Japan' o... Read More
Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063148) titled 'Induction of plasticity in the primary somatosensory cortex and enhancement ... Read More
Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063146) titled 'Effect of cough sound on breathlessness' on Oct. 2. Study Type: Interventi... Read More
Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063145) titled 'A Prospective Observational Study on Variations and Prediction of Mental and... Read More
Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More
Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634... Read More
Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wit... Read More
Singapore, Oct. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Vers... Read More